Xilio Therapeutics, Inc.
Biotechnology ResearchView the employees at
Xilio Therapeutics, Inc.-
Sallyann Vu Senior Research Associate In Vivo Pharmacology at Xilio Therapeutics, Inc.
-
Rising Star
Teleen Norman Senior Vice President Clinical Operations at Xilio Therapeutics, Inc.-
Waltham
-
Rising Star
Damiano Fantini Associate Director at $XLO - Bioinformatics | Translational Oncology-
Boston, Massachusetts, United States
-
Rising Star
Kyle Paul Smith, PhD Principal Scientist, Biophysics at Xilio Therapeutics, Inc.-
Cambridge
-
Rising Star
Carl Uli Bialucha Chief Scientific Officer at Xilio Therapeutics, Inc.-
Cambridge
-
Rising Star
Overview
Xilio is a Waltham, Massachusetts-based clinical-stage biopharmaceutical company focused on defeating cancer. The company’s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer.
-